ATC codes:
P01BE03
EMLc
Indication
Malaria due to Plasmodium vivax
ICD11 code:
1F81
INN
Artesunate
Medicine type
Chemical agent
List type
Core
(EML)
(EMLc)
(EMLc)
Additional notes
For use in the management of severe malaria
Formulations
Parenteral > General injections > IV:
60 mg in vial powder for injection ;
30 mg in vial powder for injection ;
120 mg in vial powder for injection
Local > Rectal > Other: 100 mg capsules (EMLc)
Local > Rectal > Other: 100 mg capsules (EMLc)
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of artesunate powder for injection 30 mg, 60 mg and 120 mg on the EML and EMLc;
- the deletion of the previously listed injection formulation of artesunate from the EML and EMLc;
- the deletion of 50 mg and 200 mg artesunate rectal capsules from the EML and EMLc;
- the deletion of 50 mg artesunate tablets from the EML and EMLc.
- the removal of footnotes regarding follow-up care and combination use.